Firm Overview

Since 2003, the Essex Partners (“EP”) principals have provided operational and financial support to lower middle market companies across a broad range of industries. EP was formed to invest in companies with defensible market positions, significant growth opportunities and sustainable competitive advantages.

Transaction Types

  • Control Buyouts

  • Management Buyouts

  • Growth Equity

  • Generational Transitions of Family Owned Businesses

Industry Focus

  • Healthcare

  • Business Services

  • Distribution

  • Retail / Franchise Related

  • Manufacturing


Essex Partners Platform Company SkinGenuity Announces Breakthrough Clinical Study Results

SkinGenuity, LLC (, an Essex Partners platform company, has announced the results of a breakthrough study on the use of growth factors in the treatment of Genitourinary Syndrome of Menopause (GSM).

Investment Criteria


Revenues of $5 -$50 million; EBITDA of $2 million+

Investment Structures

Equity and mezzanine debt

Investment Amounts

$2 -$20 million with capacity to finance larger investments


Control or minority positions

Investment Horizons

Long Term (no limitations)

Board Representation

Active Board Seat


United States